当前位置： SCI文献检索 > CONTRACEPTION期刊下所有文献 > Contraceptive use at last intercourse among reproductive-aged women with disabilities: an analysis of population-based data from seven states.

Contraceptive use at last intercourse among reproductive-aged women with disabilities: an analysis of population-based data from seven states.

Abstract：

OBJECTIVE:To assess patterns of contraceptive use at last intercourse among women with physical or cognitive disabilities compared to women without disabilities. STUDY DESIGN:We analyzed responses to 12 reproductive health questions added by seven states to their 2013 Behavioral Risk Factor Surveillance System questionnaire. Using responses from female respondents 18-50 years of age, we performed multinomial regression to calculate estimates of contraceptive use among women at risk for unintended pregnancy by disability status and type, adjusted for age, race/ethnicity, marital status, education, health insurance status, and parity. RESULTS:Women with disabilities had similar rates of sexual activity as women without disabilities (90.0% vs. 90.6%, p=.76). Of 5995 reproductive-aged women at risk for unintended pregnancy, 1025 (17.1%) reported one or more disabilities. Contraceptive use at last intercourse was reported by 744 (70.1%) of women with disabilities compared with 3805 (74.3%) of those without disabilities (p=.22). Among women using contraception, women with disabilities used male or female permanent contraception more often than women without disabilities (333 [29.6%] versus 1337 [23.1%], p<.05). Moderately effective contraceptive (injection, oral contraceptive, patch, or ring) use occurred less frequently among women with cognitive (13.1%, n=89) or independent living (13.9%, n=40) disabilities compared to women without disabilities (22.2%, n=946, p<.05). CONCLUSIONS:The overall prevalence of sexual activity and contraceptive use was similar for women with and without physical or cognitive disabilities. Method use at last intercourse varied based on presence and type of disability, especially for use of permanent contraception. IMPLICATIONS:Although women with disabilities were sexually active and used contraception at similar rates as women without disabilities, contraception use varied by disability type, suggesting the importance of this factor in reproductive health decision-making among patients and providers, and the value of further research to identify reasons why this occurs.

journal_name

Contraception

journal_title

Contraception

authors

Haynes RM,Boulet SL,Fox MH,Carroll DD,Courtney-Long E,Warner L

doi

10.1016/j.contraception.2017.12.008

subject

Has Abstract

pub_date

2018-06-01 00:00:00

pages

538-545

issue

6

eissn

0010-7824

issn

1879-0518

pii

S0010-7824(17)30534-6

journal_volume

97

pub_type

杂志文章

相关文献

CONTRACEPTION文献大全
  • Four-year experience in a randomized study of the Gyne T 380 Slimline and the Standard Gyne T 380 intrauterine copper devices.

    abstract：:Performance of the Slimline and Standard models of the Gyne T 380 were measured through four years in a comparative study initially involving 996 women, seventy percent of whom were randomized to the Slimline device. Cumulative pregnancy rates of Slimline users were 0.3 +/- 0.2 per 100 both at three and at four years,...

    journal_title：Contraception

    pub_type： 临床试验,杂志文章,随机对照试验

    doi：10.1016/0010-7824(93)90107-i

    authors： Sivin I,Diaz J,Alvarez F,Brache V,Diaz S,Pavez M,Stern J

    更新日期：1993-01-01 00:00:00

  • Vaginal misoprostol compared with vaginal gemeprost in termination of second trimester pregnancy. A randomized trial.

    abstract：:A prospective randomized trial was conducted in 140 women to compare the efficacy of vaginal gemeprost with vaginal misoprostol for termination of second trimester pregnancy. Women requesting termination of second trimester pregnancy were randomized into two groups. Group A women were given 1 mg vaginal gemeprost ever...

    journal_title：Contraception

    pub_type： 临床试验,杂志文章,随机对照试验

    doi：10.1016/s0010-7824(98)00099-7

    authors： Wong KS,Ngai CS,Wong AY,Tang LC,Ho PC

    更新日期：1998-10-01 00:00:00

  • Interleukin-6 and tumor necrosis factor-alpha concentrations in the intrauterine cavity of postmenopausal women using an intrauterine delivery system releasing progesterone. A possible mechanism of action of the intrauterine device.

    abstract：:Intrauterine devices (IUD) provide effective contraception. The current study evaluates the concentration of interleukin-6 (IL-6) and tumor necrosis factor-alpha (TNF-alpha) in the intrauterine fluid of postmenopausal women using an intrauterine delivery system releasing progesterone (IDS-P). Intrauterine fluid was ob...

    journal_title：Contraception

    pub_type： 临床试验,杂志文章,随机对照试验

    doi：10.1016/s0010-7824(99)00014-1

    authors： Archer DF,DeSoto KR,Baker JM

    更新日期：1999-03-01 00:00:00

  • Release of proteolytic enzymes from leucocytes attached to IUDs.

    abstract：:The leucocytes adhering to intrauterine devices (IUDs) were predominantly mononuclear phagocytic cells (MPCs) and granulocytes. These cells released elastase and a plasminogen activator in the culture medium. The plasminogen activator was found to be immunologically identical to tissue activator, and the release patte...

    journal_title：Contraception

    pub_type： 杂志文章

    doi：10.1016/0010-7824(82)90083-x

    authors： Casslén B,Ohlsson K,Lindholm K,Astedt B

    更新日期：1982-08-01 00:00:00

  • Combined hormonal contraception and bone health: a systematic review.

    abstract：:This systematic review examined whether women who use combined hormonal contraception experience changes in risk of fracture or bone mineral density (BMD) that differ from nonusers. We identified 86 articles from PubMed and EMBASE (published 1966 to August 2005) that reported on fracture or BMD outcomes by use of comb...

    journal_title：Contraception

    pub_type： 杂志文章,评审

    doi：10.1016/j.contraception.2006.01.003

    authors： Martins SL,Curtis KM,Glasier AF

    更新日期：2006-05-01 00:00:00

  • Two-year treatment with oral contraceptives in hyperprolactinemic patients.

    abstract：:The aim of this prospective study was the follow-up for 2 years in symptoms, serum prolactin (PRL) levels, and radiological aspects of a group of young patients using oral contraceptives (OC) with hyperprolactinemia. A total of 16 hyperprolactinemic women (eight with idiopathic hyperprolactinemia and eight with pituit...

    journal_title：Contraception

    pub_type： 临床试验,杂志文章

    doi：10.1016/s0010-7824(98)00069-9

    authors： Testa G,Vegetti W,Motta T,Alagna F,Bianchedi D,Carlucci C,Bianchi M,Parazzini F,Crosignani PG

    更新日期：1998-08-01 00:00:00

  • Associations of mental illness and substance use disorders with prescription contraception use among women veterans.

    abstract：OBJECTIVE:To investigate whether mental illness and substance use disorder (SUD) are associated with having a prescription contraceptive method among women veterans. STUDY DESIGN:We conducted a retrospective analysis of National Veterans Administration (VA) administrative and clinical data for women veterans aged 18-4...

    journal_title：Contraception

    pub_type： 杂志文章

    doi：10.1016/j.contraception.2014.02.028

    authors： Callegari LS,Zhao X,Nelson KM,Lehavot K,Bradley KA,Borrero S

    更新日期：2014-07-01 00:00:00

  • Restoring testosterone levels by adding dehydroepiandrosterone to a drospirenone containing combined oral contraceptive: I. Endocrine effects.

    abstract：OBJECTIVES:Combined oral contraceptives (COCs) decrease testosterone (T) levels. This study investigated restoration of T and other androgen concentrations during COC use by 'co-administration' of dehydroepiandrosterone (DHEA). STUDY DESIGN:In this randomized, double-blind, placebo-controlled study in 99 new COC start...

    journal_title：Contraception

    pub_type： 杂志文章,随机对照试验

    doi：10.1016/j.contraception.2014.11.002

    authors： Zimmerman Y,Foidart JM,Pintiaux A,Minon JM,Fauser BC,Cobey K,Coelingh Bennink HJ

    更新日期：2015-02-01 00:00:00

  • Atypical presentation of serious pelvic inflammatory disease following mifepristone-induced medical abortion.

    abstract：:Mifepristone-induced abortion is increasingly common. Recent alerts have highlighted the occurrence of infrequent but serious complications. We report a case of serious bacterial infection after medical termination that occurred in the absence of the usual signs of infection. ...

    journal_title：Contraception

    pub_type： 杂志文章

    doi：10.1016/j.contraception.2005.09.003

    authors： Lawton BA,Rose SB,Shepherd J

    更新日期：2006-04-01 00:00:00

  • Hormonal contraception, breastfeeding and bedside advocacy: the case for patient-centered care.

    abstract：:Postpartum contraceptive decision making is complex, and recommendations may be influenced by breastfeeding intentions. While biologically plausible, concerns about the adverse impact of hormonal contraception on breast milk production have not been supported by the clinical evidence to date. However, the data have li...

    journal_title：Contraception

    pub_type： 社论

    doi：10.1016/j.contraception.2018.10.011

    authors： Bryant AG,Lyerly AD,DeVane-Johnson S,Kistler CE,Stuebe AM

    更新日期：2019-02-01 00:00:00

  • Comparison of remote and in-clinic follow-up after methotrexate/misoprostol abortion.

    abstract：OBJECTIVE:This study compared adherence to follow-up and clinical outcomes between standard in-clinic and remote follow-up after methotrexate/misoprostol abortion. STUDY DESIGN:This nonrandomized trial recruited women requesting medical abortion at two sexual health clinics in Toronto, Canada. Women received methotrex...

    journal_title：Contraception

    pub_type： 临床试验,杂志文章

    doi：10.1016/j.contraception.2015.05.013

    authors： Dunn S,Panjwani D,Gupta M,Meaney C,Morgan R,Feuerstein E

    更新日期：2015-09-01 00:00:00

  • Effects of levonorgestrel-releasing subdermal contraceptive implants on bone density and bone metabolism.

    abstract：:A prospective, randomized clinical trial observed the effects of Norplant long-term contraceptive implants and domestic implants similar to Norplant on bone mineral density and bone metabolism in female acceptors for 1 year. Bone mineral density (BMD) and bone mineral content (BMC) of lumbar 2-4 and proximal femur of ...

    journal_title：Contraception

    pub_type： 临床试验,杂志文章,随机对照试验

    doi：10.1016/s0010-7824(99)00080-3

    authors： Di X,Li Y,Zhang C,Jiang J,Gu S

    更新日期：1999-09-01 00:00:00

  • Medicaid and fulfillment of desired postpartum sterilization.

    abstract：OBJECTIVE:We sought to assess fulfillment of sterilization requests while accounting for the complex interplay between insurance, clinical and social factors in a contemporary context that included both inpatient and outpatient postpartum sterilization procedures. STUDY DESIGN:This is a retrospective single-center coh...

    journal_title：Contraception

    pub_type： 杂志文章

    doi：10.1016/j.contraception.2018.02.012

    authors： Arora KS,Wilkinson B,Verbus E,Montague M,Morris J,Ascha M,Mercer BM

    更新日期：2018-06-01 00:00:00

  • Improving hysterosalpingogram confirmatory test follow-up after Essure hysteroscopic sterilization.

    abstract：BACKGROUND:Given the need for a 90-day post-Essure hysterosalpingogram (HSG) to confirm proper tubal placement and occlusion, we examined the impact of dedicating a staff nurse to schedule HSG appointments, call with appointment reminders and track HSG compliance for patients who had Essure. STUDY DESIGN:We performed ...

    journal_title：Contraception

    pub_type： 杂志文章

    doi：10.1016/j.contraception.2010.01.019

    authors： Guiahi M,Goldman KN,McElhinney MM,Olson CG

    更新日期：2010-06-01 00:00:00

  • Response to requests for contraception in one direct-to-consumer telemedicine service.

    abstract：OBJECTIVE:To describe real-world care seeking and contraception provision in one direct to consumer telemedicine platform. STUDY DESIGN:We described encounters with reproductive age female patients between July 2016 and July 2018 seeking contraception on the American Well telemedicine platform. RESULTS:Of 126,712 tot...

    journal_title：Contraception

    pub_type： 杂志文章

    doi：10.1016/j.contraception.2020.01.017

    authors： Martinez KA,Rastogi R,Lipold L,Rothberg MB

    更新日期：2020-05-01 00:00:00

  • The effect of some beta -adrenergic blocking agents on ovulation in rabbits.

    abstract：:The effect of propanolol hydrochloride (PH) and oxprenolol hydrochloride (OH) on ovulation was studied in mature rabbits. PH-treated animals did not accept mating and ovulation was suppressed after forced mating. 5 of 6 OH-treated animals refused mating. No implantation sites or corpora lutea were found in the anim...

    journal_title：Contraception

    pub_type： 杂志文章

    doi：10.1016/s0010-7824(75)80036-9

    authors： Foda MS,Darwish NA,Shafeek AA,Sharaf EM,Zaki MA

    更新日期：1975-07-01 00:00:00

  • Medical conditions, pregnancy perspectives and contraceptive decision-making among young people: an exploratory, qualitative analysis.

    abstract：OBJECTIVE:To explore perspectives on family planning among young people who perceive they are infertile or will have difficulty carrying a pregnancy to term owing to medical conditions or procedures. METHODS:This exploratory analysis examined pregnancy plans and contraceptive behavior among 12 young adults with a diag...

    journal_title：Contraception

    pub_type： 杂志文章

    doi：10.1016/j.contraception.2019.03.046

    authors： Gomez AM,Arteaga S,Ingraham N,Arcara J

    更新日期：2019-07-01 00:00:00

  • Comparison of rates of and charges from pregnancy complications in users of extended and cyclic combined oral contraceptive (COC) regimens: a brief report.

    abstract：OBJECTIVE:To evaluate pregnancy complication rates and related charges in users of 84/7, 21/7 and 24/4 combined oral contraceptives (COCs). STUDY DESIGN:Data were obtained from the i3 InVision Data Mart™ retrospective claims database. Subjects were aged 15-40 years, first prescribed a COC between 1/1/2006 and 4/1/2011...

    journal_title：Contraception

    pub_type： 杂志文章

    doi：10.1016/j.contraception.2013.12.006

    authors： Howard B,Trussell J,Grubb E,Lage MJ

    更新日期：2014-05-01 00:00:00

  • Effects of DL111-IT or combined with RU486 on uterine polyamines biosynthesis in rats during early gestation.

    abstract：:DL111-IT, a non-hormonal contragestional agent, revealed synergistic effects in combination with mifepristone (RU486) in some species. The present study was undertaken to clarify the role of DL111-IT when used alone or plus RU486 on uterine polyamines biosynthesis, histologic alteration of decidual cells, and antifert...

    journal_title：Contraception

    pub_type： 杂志文章

    doi：10.1016/s0010-7824(01)00197-4

    authors： Shentu J,Zhou H,He Q,Wang L,Fang R

    更新日期：2001-05-01 00:00:00

  • Characteristics of menstrual problems associated with Norplant discontinuation: results of a multinational study.

    abstract：:This paper presents a secondary analysis of 3419 Norplant users from 11 countries throughout Asia, Africa and Latin America. The main objective was to identify the menstrual problems associated with a high risk of early discontinuation of Norplant use. Eligible participants were divided into two groups: those who cont...

    journal_title：Contraception

    pub_type： 杂志文章

    doi：10.1016/s0010-7824(03)00040-4

    authors： Rivera R,Rountree W

    更新日期：2003-05-01 00:00:00

  • Consequences of uterine blood loss caused by various intrauterine contraceptive devices in South American women. World Health Organization Special Programme of Research, Development and Research Training in Human Reproduction.

    abstract：:Increased menstrual blood loss (MBL) associated with intrauterine device (IUD) use may precipitate or aggravate iron deficiency anaemia, adversely affecting the health of women particularly those from developing countries. Studies were conducted to define the association of MBL and iron status in South American women;...

    journal_title：Contraception

    pub_type： 临床试验,杂志文章,随机对照试验

    doi：10.1016/0010-7824(88)90091-1

    authors： Andrade AT,Pizarro E,Shaw ST Jr,Souza JP,Belsey EM,Rowe PJ

    更新日期：1988-07-01 00:00:00

  • FDA requirements for nonclinical testing of contraceptive steroids.

    abstract：:Written guidelines for the preclinical testing of contraceptive steroids have not been revised since 1968 despite the fact that many important changes have been implemented by the FDA's Division of Metabolism and Endocrine Drug Products. This paper describes the new preclinical testing requirements and the rationale f...

    journal_title：Contraception

    pub_type： 指南,杂志文章

    doi：10.1016/0010-7824(92)90114-9

    authors： Jordan A

    更新日期：1992-12-01 00:00:00

  • Inhibition of LH-induced ovulation in the rat by a hormonal antagonist.

    abstract：:A chemically deglycosylated derivative of ovine luteinizing hormone (LH) exhibited appreciable binding to the receptor but had minimal steroidogenic activity. In immature female rats primed with pregnant mare serum gonadotropin, the deglycosylated LH showed low ovulation-inducing activity. Ovulation induced by ovine L...

    journal_title：Contraception

    pub_type： 杂志文章

    doi：10.1016/0010-7824(80)90037-2

    authors： Sairam MR

    更新日期：1980-06-01 00:00:00

  • Did increasing use of highly effective contraception contribute to declining abortions in Iowa?

    abstract：BACKGROUND:Between 2006 and 2008, Iowa increased access to family planning services through a Medicaid expansion and a privately funded initiative. During this same time, Iowa expanded access to abortion through telemedicine provision of medical abortion. Despite increased access to abortion services, abortions in Iowa...

    journal_title：Contraception

    pub_type： 杂志文章

    doi：10.1016/j.contraception.2014.10.009

    authors： Biggs MA,Rocca CH,Brindis CD,Hirsch H,Grossman D

    更新日期：2015-02-01 00:00:00

  • Midtrimester abortion with intramuscular injection of 15-methyl-prostaglandin F2alpha.

    abstract：:This study examines the efficacy and side effects of 15-methyl-prostaglandins F2alpha (PGF2a) free acid administered intramuscularly for midtrimester abortion. 50 healthy women aged 14 to 37 years and between 12 to 18 weeks gestation were randomly selected from the abortion clinic at the Los Angeles County/USC Medica...

    journal_title：Contraception

    pub_type： 杂志文章

    doi：10.1016/0010-7824(75)90107-9

    authors： Slaughter L,Ballard CA

    更新日期：1975-05-01 00:00:00

  • Emetine ditartrate: a possible lead for emergency contraception.

    abstract：:Interception of pregnancy in its initial stage is an attractive and viable approach to contraception. A chemical agent, taken within the first few days of missed menses, intercepts the conception, which is expelled with menstrual flow. The main targets of such agents are the uterus, blastocyst and the growing trophobl...

    journal_title：Contraception

    pub_type： 杂志文章

    doi：10.1016/j.contraception.2003.12.011

    authors： Mehrotra PK,Kitchlu S,Dwivedi A,Agnihotri PK,Srivastava S,Roy R,Bhaduri AP

    更新日期：2004-05-01 00:00:00

  • Use of intramuscular prostaglandin for failure of mid-trimester abortion by another method.

    abstract：:Eight investigators, using a common protocol, studied the use of intramuscular (15S)-15-methyl prostaglandin F2 alpha to abort midtrimester pregnancies which had failed treatment by other methods in 398 cases. Results of treatment of 3 subgroups, defined by reason for primary treatment failure, are presented. The comb...

    journal_title：Contraception

    pub_type： 杂志文章

    doi：10.1016/0010-7824(80)90088-8

    authors： Schwallie PC,Huang DC,Turner LF

    更新日期：1980-12-01 00:00:00

  • Cell-cell interactions in the local control of seminiferous tubule contractility.

    abstract：:Since peritubular smooth muscle cells (PSMCs) have been characterized, isolated and cultured in homogeneous populations, the regulation of seminiferous epithelium contractility has received increasing attention. The present article reports and discusses experimental evidence demonstrating that: (1) PSMCs express two t...

    journal_title：Contraception

    pub_type： 杂志文章,评审

    doi：10.1016/s0010-7824(01)00319-5

    authors： Palombi F,Filippini A,Chiarenza C

    更新日期：2002-04-01 00:00:00

  • A repeat dose of misoprostol 800 mcg following mifepristone for outpatient medical abortion at 64-70 and 71-77 days of gestation: A retrospective chart review.

    abstract：OBJECTIVE:To compare the effectiveness of outpatient medical abortion with mifepristone 200 mg and two misoprostol 800 mcg doses at 64-70 and 71-77 days of gestation. STUDY DESIGN:We conducted a retrospective chart review of medical abortion outcomes among clients with 64-77 day gestations at a Mexico City public clin...

    journal_title：Contraception

    pub_type： 杂志文章

    doi：10.1016/j.contraception.2020.05.012

    authors： Dzuba IG,Castillo PW,Bousiéguez M,Lugo Hernández EM,Castañeda Vivar JJ,Sanhueza Smith P

    更新日期：2020-08-01 00:00:00

  • Acceptability evaluation of a natural rubber latex, a polyurethane, and a new non-latex condom.

    abstract：:After more than a century of reliance on latex condoms, male condoms fabricated from new materials are finally becoming commercially available to consumers. This study was an open label acceptability study that compared three lubricated condom products during vaginal intercourse: a natural rubber latex condom, a polyu...

    journal_title：Contraception

    pub_type： 临床试验,杂志文章,随机对照试验

    doi：10.1016/s0010-7824(00)00119-0

    authors： Frezieres RG,Walsh TL

    更新日期：2000-06-01 00:00:00